Transmyocardial revascularization ameliorates ischemia by attenuating paradoxical catecholamine-induced vasoconstriction

Journal of Nuclear Cardiology

Volumn 14, Issue 2, 2007, Pages 207-214

  Le, D Elizabeth ^a,b   Powers, Eric R ^a,c   Bin, Jian Ping ^a   Leong Poi, Howard ^a,d   Goodman, N Craig ^a   Kaul, Sanjiv ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Cardiomyopathy; ischemia; lasers; revascularization

Indexed keywords

(3 IODOBENZYL)GUANIDINE; CATECHOLAMINE; IODINE 123; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY CONSTRICTION; DOG; ENZYME ACTIVITY; EXERCISE TOLERANCE; HEART INNERVATION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; NORADRENERGIC NERVE; PRIORITY JOURNAL; VASOCONSTRICTION;

ANIMALS; CATECHOLAMINES; CORONARY CIRCULATION; DOGS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; TREATMENT OUTCOME; VASOCONSTRICTION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33947408375     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2006.12.328     Document Type: Article

References (48)

1. Frazier O.H., Cooley D.A., Kadipasaoglu K.A., Pehlivanoglu S., Lindemeier M., Barasch E., et al. Myocardial revascularization with laser. Preliminary findings. Circulation 92 Suppl II (1995) II58-II65
2. Cooley D.A., Frazier O.H., Kadipasaoglu K.A., Lindenmeier M., Pehlivanoglu S., Kolff J.W., et al. Transmyocardial laser revascularization: clinical experience with twelve-month follow-up. J Thorac Cardiovasc Surg 111 (1996) 791-799
3. Horvath K.A., Mannting F., Cummings N., Shernan S.K., and Cohn L.H. Transmyocardial laser revascularization: operative techniques and clinical results at two years. J Thorac Cardiovasc Surg 111 (1996) 1047-1053
4. Horvath K.A., Cohn L.H., Cooley D.A., Crew J.R., Frazier O.H., Griffith B.P., et al. Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. J Thorac Cardiovasc Surg 113 (1997) 645-654
5. Kornowski R., Baim D.S., Moses J., Hong M.K., Laham R.J., Fuch S., et al. Short- and intermediate-term clinical outcomes from direct myocardial laser revascularization guided by biosense left ventricular electromechanical mapping. Circulation 102 (2000) 1120-1125
6. Milano A., Pratali S., Tartarini G., Mariotti R., De Carlo M., Paterni G., et al. Early results of transmyocardial revascularization with a holmium laser. Ann Thorac Surg 65 (1998) 700-704
7. Donovan C.L., Landolfo K.P., Lowe J.E., Clements F., Coleman R.B., and Ryan T. Improvement in inducible ischemia during dobutamine stress echocardiography after transmyocardial laser revascularization in patients with refractory angina. J Am Coll Cardiol 30 (1997) 607-612
8. Oesterle S., Sanborn T.A., Ali N., Resar J., Ramee S.R., Heuser R., et al. Percutaneous myocardial laser revascularization for severe angina: the PACIFIC randomised trial. Lancet 356 (2000) 1705-1710
9. Lauer B., Junghans U., Stahl F., Kluge R., Oesterle S.N., and Schuler G. Catheter-based percutaneous myocardial laser revascularization in patients with end-stage coronary artery disease. J Am Coll Cardiol 34 (1999) 1663-1670
10. Allen K.B., Dowling R.D., Fudge T.L., Schoettle G.P., Selinger S.L., Gangahar D.M., et al. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med 341 (1999) 1029-1036
11. Burkhoff D., Schmidt S., Schulman S.P., Myers J., Resar J., Becker L.C., et al. Transmyocardial laser revascularization compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomized trial. ATLANTIC investigators: Angina Treatments-Lasers and Normal Therapies in Comparison. Lancet 354 (1999) 885-890
12. Frazier O.H., March R.J., and Horvath K.A. Transmyocardial revascularization with carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med 341 (1999) 1021-1028
13. Schofield P.M., Sharples L.D., Caine N., Burns S., Tait S., Wistow T., et al. Transmyocardial laser revascularization in patients with refractory angina: a randomized controlled trial. Lancet 353 (1999) 519-524
14. Deckelbaum L.I. Cardiovascular applications of laser technology. Lasers Surg Med 15 (1994) 315-341
15. Mirrhoseini M., Muckerheide M., and Cayton M.M. Transventricular revascularization by laser. Lasers Surg Med 2 (1982) 187-198
16. Cooley D.A., Frazier O.H., Kadipasaoglu K.A., Pehlivanoglu S., Shannon R.L., and Angelini P. Transmyocardial laser revascularization: anatomic evidence of long-term channel patency. Tex Heart Inst J 21 (1994) 220-224
17. Hughes G.C., Lowe J.E., Kypson A.P., St Louis J.D., Pippen A.M., Peters K.G., et al. Neovascularization after transmyocardial laser revascularization in a model of chronic ischemia. Ann Thorac Surg 66 (1998) 2029-2036
18. Yamamoto N., Takushi K., Anguo G., DeRosa C., Smith C.R., and Burkhoff D. Angiogenesis is enhanced in ischemic canine myocardium by transmyocardial laser revascularization. J Am Coll Cardiol 31 (1998) 1426-1433
19. Chu V.F., Giaid A., Kuang J., McGinn A.N., Li C.M., Pelletier M.P., et al. Angiogenesis in transmyocardial revascularization: comparison of laser versus mechanical punctures. Ann Thorac Surg 68 (1999) 301-308
20. Hughes G.C., Kypson A.P., Annex B.H., Yin B., St Louis J.D., Biswas S.S., et al. Induction of angiogenesis after TMR: a comparison of holmium:YAG, CO2, and excimer lasers. Ann Thorac Surg 70 (2000) 504-509
21. Domkowski P.W., Biswas S.S., Steenbergen C., and Lowe J.E. Histological evidence of angiogenesis 9 months after transmyocardial revascularization. Circulation 103 (2001) 469-471
22. Al-Shiekh T., Allen K.B., Straka S.P., Heimansohn D.A., Fain R.L., Hutchins G.D., et al. Cardiac sympathetic denervation after transmyocardial laser revascularization. Circulation 100 (1999) 135-140
23. Minisi A.J., Topaz O., Quinn M.S., and Mohnaty L.B. Cardiac nociceptive reflexes after transmyocardial laser revascularization: implications for the neural hypothesis of angina relief. J Thorac Cardiovasc Surg 122 (2001) 712-719
24. Barbato E., Bartunel J., Wyffels E., Wijns W., Heyndrickx G.R., and De Bruyne B. Effects of intravenous dobutamine on coronary vasomotion in humans. J Am Coll Cardiol 42 (2003) 1596-1601
25. Brown B.G., Lee A.B., Bolson E.L., and Dodge H.T. Reflex constriction of significant coronary stenosis as a mechanism contributing to ischemic left ventricular dysfunction during isometric exercise. Circulation 70 (1984) 18-24
26. Gage J.E., Hess O.M., Murakami T., Ritter M., Grimm J., and Krayenbuehl H.P. Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin. Circulation 73 (1986) 865-876
27. Gordon J.B., Ganz P., Nabel E.G., Fish R.D., Zebede J., Mudge G.H., et al. Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. J Clin Invest 83 (1989) 1946-1952
28. Nabel E.G., Ganz P., Gordon J.B., Alexander R.W., and Selwyn A.P. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation 77 (1988) 43-52
29. Firoozan S., Wei K., Linka A., Skyba D., Goodman N.C., and Kaul S. A canine model of chronic ischemic cardiomyopathy: characterization of regional flow-function relations. Am J Physiol 276 (1999) H446-H455
30. Pelberg R.A., Spotnitz W.D., Bin J.-P., Le E., Goodman N.C., and Kaul S. Mechanism of myocardial dysfunction in the presence of chronic coronary stenosis and normal resting myocardial blood flow: clinical implications. J Am Soc Echocardiogr 14 (2001) 1047-1056
31. Sklenar J., Jayaweera A.R., and Kaul S. A computer-aided approach for the quantification of regional left ventricular function using two-dimensional echocardiography. J Am Soc Echocardiogr 5 (1992) 33-40
32. Heymann M.A., Payne B.D., Hoffman J.I., and Rudolph A.M. Blood flow measurements with radionuclide-labeled particles. Prog Cardiovasc Dis 20 (1997) 55-79
33. Dae M.W., O'Connell J.W., Botvinick E.H., Ahearn T., Yee E., Huberty J.P., et al. Scintigraphic assessment of regional cardiac adrenergic innervation. Circulation 79 (1989) 634-644
34. Himura Y., Felten S., Kashiki M., Lewandowski T.J., Delehanty J.M., and Liang C.-S. Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure. Circulation 88 (1993) 1299-1309
35. Fishbein M.C., Meerbaum S., Rit J., Lando U., Kanmatsuse K., Mercier J.C., et al. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 101 (1981) 593-600
36. Arora R.C., Hirsch G.M., Hirsch M.D., and Armour J.A. Transmyocardial laser revascularization remodels the intrinsic cardiac nervous system in a chronic setting. Circulation 104 Suppl I (2001) I115-I120
37. Beek J.F., van der Sloot J.A.P., Huikeshoven M., Verberne H.J., van Eck-Smit B.L., van der Meulen J., et al. Cardiac denervation after clinical transmyocardial laser revascularization: short-term and long-term iodine 123-labeled meta-iodobenzylguanine scintigraphic evidence. J Thorac Cardiovasc Surg 127 (2004) 517-524
38. Hirsch G.M., Thompson G.W., Arora R.C., Hirsch K.J., Sullican J.A., and Armour J.A. Transmyocardial laser revascularization does not denervate the canine heart. Ann Thorac Surg 68 (1999) 460-469
39. Johnson L.L., Thambar S., Donahay T., Dae M., and Williams D.O. Effect endomyocardial laser channels on regional innervation shown with 125I-MIBG and autoradiography. J Nucl Med 43 (2002) 551-555
40. Raff M.C., Whitmore A.V., and Finn J.T. Axonal self-destruction and neurodegeneration. Science 296 (2002) 868-871
41. Luo L., and O'Leary D.D.M. Axon retraction and degeneration in health and disease. Ann Rev Neurosci 28 (2005) 127-156
42. Valette H., Deleuze P., Syrota A., Delforge J., Crouzel C., Fuseau C., et al. Canine myocardial beta-adrenergic, muscarinic receptor densities after denervation: a PET study. J Nucl Med 36 (1995) 140-146
43. Vatner D.E., Lavelle M., Amano J., Finizola A., Homcy C.J., and Vatner S.F. Mechanisms of supersensitivity to sympathomimetic amines in the chronically denervated heart of the conscious dog. Circ Res 57 (1985) 55-64
44. Vergroesen I., Merkus D., van Teeffelen J.W.G.E., Dankelman J., Spaan J.A.S., van Wezel H.B., et al. Chronic cardiac denervation affects the speed of coronary vascular regulation. Cardiovasc Res 44 (1999) 615-622
45. Nagata M., Pichet R., and Lavallee M. Coronary dilation with carotid chemoreceptor stimulation in cardiac-denervated dogs. Am J Physiol 255 (1988) H1331-H1335
46. Shen Y.T., Knight D.R., Vatner S.F., Randall W.C., and Thomas J.X. Responses to coronary artery occlusion in the conscious dog with selective cardiac denervation. Am J Physiol 255 (1988) H525-H533
47. Shen Y.T., Knight D.R., Thomas J.X., and Vatner S.F. Effects of selective cardiac denervation on collateral blood flow after coronary artery occlusion in conscious dogs. Basic Res Cardiol 85 Suppl 1 (1990) 229-239
48. 2 laser. Ann Thorac Surg 63 (1997) 1275-1283